Clinical Trial Update: A Study to Determine Number of Patients Who Develop High Ammonia Levels After Receiving Recombinant Erwinia Asparaginase

View source ↗

Summary

This clinical trial update describes a study to determine how many patients develop elevated ammonia levels after receiving recombinant Erwinia asparaginase. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Recombinant Erwinia asparaginase (Erwinia asparaginase)

Snippet

Sponsor: Mayo Clinic | Conditions: Hematopoietic and Lymphatic System Neoplasm, Acute Lymphobkastic Leukemia | Status: RECRUITING